Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) affects 1 in 5 women of reproductive age, and is characterized by menstrual irregularities, clinical or biochemical hyperandrogenism, and the presence of polycystic ovary morphology. One of the recommended treatment strategies in the international evidence-based guidelines is lifestyle modification, which includes diet and exercise, with the aim of improving a range of health outcomes. The incurable nature of PCOS reinforces the importance of developing novel and innovative symptomatic relief strategies, which are currently the only available approaches for improving quality of life for these women. Women with PCOS tend to be nutrient deficient in many common vitamins and minerals, thought to be associated with the psychological (depression, anxiety, etc.) and physiological (insulin resistance, diabetes, infertility, etc.) sequelae of the condition. Nutrient supplementation and the integration of complementary medicine as adjuncts to traditional lifestyle-based therapies in PCOS could therefore provide additional benefits to these women. In this review, we synthesize the evidence regarding nutrient supplementation and complementary therapies in PCOS, predominantly from randomized controlled trials, systematic reviews, and meta-analyses, to provide an overview of the state of knowledge in this field. The evidence to date suggests that specific vitamins (B-12, inositols, folate, vitamins D, E, and K), vitamin-like nutrients (bioflavonoids and α-lipoic acid), minerals (calcium, zinc, selenium, and chromium picolinate), and other formulations (melatonin, ω-3 fatty acids, probiotics, and cinnamon), as well as some complementary approaches such as acupuncture and yoga may be beneficial in PCOS. However, there remain areas of uncertainty and key limitations in the literature that must be overcome before these therapies can be integrated into routine clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Raygan, F., Ostadmohammadi, V., Bahmani, F., Reiter, R. J., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.004 · Cited by 147
RetractedEndocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Self-citationThe clinical use of mindfulness meditation for the self-regulation of chronic pain
Kabat-Zinn, J., Lipworth, L., & Burney, R. (1985) · Journal of Behavioral Medicine · doi:10.1007/bf00845519 · Cited by 1,745
Chiesa, A., & Serretti, A. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0495 · Cited by 1,681
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Self-citationB Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review
Kennedy, D. (2016) · Nutrients · doi:10.3390/nu8020068 · Cited by 1,055
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Self-citationMolecular aspects of lipoic acid in the prevention of diabetes complications
Packer, L., Kraemer, K., & Rimbach, G. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00658-x · Cited by 556
Strauss, C., Cavanagh, K., Oliver, A., & Pettman, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096110 · Cited by 495
Rodríguez-Morán, M., & Guerrero-Romero, F. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1147 · Cited by 429
Lindheim, L., Bashir, M., Münzker, J., Trummer, C., Zachhuber, V., Leber, B., Horvath, A., Pieber, T. R., Gorkiewicz, G., Stadlbauer, V., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168390 · Cited by 416
Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415
Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism
Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02153 · Cited by 399
Cormick, G., & Belizán, J. M. (2019) · Nutrients · doi:10.3390/nu11071606 · Cited by 388
Obesity and Polycystic Ovary Syndrome
Sam, S. (2007) · Obesity Management · doi:10.1089/obe.2007.0019 · Cited by 255
Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis
Brutocao, C., Zaiem, F., Alsawas, M., Morrow, A. S., Murad, M. H., & Javed, A. (2018) · Endocrine · doi:10.1007/s12020-018-1692-3 · Cited by 251
The role of genes and environment in the etiology of PCOS
Diamanti-Kandarakis, E., Kandarakis, H., & Legro, R. S. (2006) · Endocrine · doi:10.1385/endo:30:1:19 · Cited by 233
Mindfulness-based interventions for weight loss: A systematic review and meta-analysis
Carrière, K., Khoury, B., Günak, M. M., & Knäuper, B. (2018) · Obesity Reviews · doi:10.1111/obr.12623 · Cited by 221
The History of Modern Yoga: Patanjali and Western Esotericism
de Michelis, E. (2006) · Nova Religio · doi:10.1525/nr.2006.9.3.141 · Cited by 194
The Effects of Magnesium Supplementation on Subjective Anxiety and Stress—A Systematic Review
Boyle, N., Lawton, C., & Dye, L. (2017) · Nutrients · doi:10.3390/nu9050429 · Cited by 162
Heshmati, J., Moini, A., Sepidarkish, M., Morvaridzadeh, M., Salehi, M., Palmowski, A., Mojtahedi, M. F., & Shidfar, F. (2021) · Phytomedicine · doi:10.1016/j.phymed.2020.153395 · Cited by 142
Pundir, J., Psaroudakis, D., Savnur, P., Bhide, P., Sabatini, L., Teede, H., Coomarasamy, A., & Thangaratinam, S. (2018) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14754 · Cited by 115
Teede, H. J., Misso, M. L., Boyle, J. A., Garad, R. M., McAllister, V., Downes, L., Gibson‐Helm, M., Hart, R. J., Rombauts, L., Moran, L., et al. (2018) · Medical Journal of Australia · doi:10.5694/mja18.00656 · Cited by 115
Self-citationReflections on inositol(s) for PCOS therapy: steps toward success
Nestler, J. E., & Unfer, V. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1054802 · Cited by 106
Yang, K., Zeng, L., Bao, T., & Ge, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0346-x · Cited by 103
Sohaei, S., Amani, R., Tarrahi, M. J., & Ghasemi-Tehrani, H. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102201 · Cited by 100
Jamilian, M., Foroozanfard, F., Mirhosseini, N., Kavossian, E., Aghadavod, E., Bahmani, F., Ostadmohammadi, V., Kia, M., Eftekhar, T., Ayati, E., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00273 · Cited by 91
Razavi, M., Jamilian, M., Karamali, M., Bahmani, F., Aghadavod, E., & Asemi, Z. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-104060 · Cited by 90
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study
Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87
Binge eating behaviours and food cravings in women with polycystic ovary syndrome
Jeanes, Y. M., Reeves, S., Gibson, E. L., Piggott, C., May, V. A., & Hart, K. H. (2017) · Appetite · doi:10.1016/j.appet.2016.11.010 · Cited by 85
Günalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74
Arentz, S., Smith, C. A., Abbott, J. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-472 · Cited by 65
Thakker, D., Raval, A., Patel, I., & Walia, R. (2015) · Obstetrics and Gynecology International · doi:10.1155/2015/817849 · Cited by 54
Mindfulness‐Based Stress Reduction in Women with Overweight or Obesity: A Randomized Clinical Trial
Raja‐Khan, N., Agito, K., Shah, J., Stetter, C. M., Gustafson, T. S., Socolow, H., Kunselman, A. R., Reibel, D. K., & Legro, R. S. (2017) · Obesity · doi:10.1002/oby.21910 · Cited by 53
Krug, I., Giles, S., & Paganini, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s168944 · Cited by 50
Heydarpour, F., Hemati, N., Hadi, A., Moradi, S., Mohammadi, E., & Farzaei, M. H. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112741 · Cited by 47
Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
Hamilton, K. P., Zelig, R., Parker, A. R., & Haggag, A. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz108 · Cited by 41
Jamilian, M., & Asemi, Z. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000438465 · Cited by 38
Karamali, M., Ashrafi, M., Razavi, M., Jamilian, M., Akbari, M., & Asemi, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-104530 · Cited by 34
Liao, D., Zhong, C., Li, C., Mo, L., & Liu, Y. (2018) · Minerva Medica · doi:10.23736/s0026-4806.18.05728-2 · Cited by 31
(2019) · PubMed Central · doi:10.22088/cjim.10.4.359 · Cited by 31
Amini, L., Mojab, F., Jahanfar, S., Sepidarkish, M., Raoofi, Z., & Maleki-Hajiagha, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102245 · Cited by 30
Mokaberinejad, R., Rampisheh, Z., Aliasl, J., & Akhtari, E. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1541232 · Cited by 28
Research works printed but not linked: 150
- Apridonidze, 2005, Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 90, 1929, 10.1210/jc.2004-1045 · DOI · Paper page
- Wolf, 2018, Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity, Int J Environ Res Public Health, 15, 10.3390/ijerph15112589 · DOI · Paper page
- Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
- Sills, 2001, Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports, BMC Women's Health, 1, 3, 10.1186/1472-6874-1-3 · DOI · Paper page
- Ndefo, 2013, Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches, P T, 38, 336
- Rutkowska, 2016, Polycystic ovary syndrome and environmental toxins, Fertil Steril, 106, 948, 10.1016/j.fertnstert.2016.08.031 · DOI · Paper page
- Mousa, 2020, Prevention and management of gestational diabetes using vitamin D supplementation: an overview and appraisal of applied sciences, Appl Sci, 10, 10.3390/app10228141 · DOI
- Mousa, 2017, 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort, J Steroid Biochem Mol Biol, 173, 258, 10.1016/j.jsbmb.2016.12.008 · DOI
- Miao, 2020, Effect of vitamin D supplementation on polycystic ovary syndrome: a meta-analysis, Exp Ther Med, 19, 2641
- Guo, 2020, Vitamin D supplementation ameliorates metabolic dysfunction in patients with PCOS: a systematic review of RCTs and insight into the underlying mechanism, Int J Endocrinol, 2020, 1, 10.1155/2020/7850816 · DOI
- Gao, 2021, The effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials, Int J Endocrinol, 2021, 1
- Nestler, 1998, Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system, J Clin Endocrinol Metab, 83, 2001
- Unfer, 2017, Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials, Endocrine Connections, 6, 647, 10.1530/EC-17-0243 · DOI · Paper page
- Unfer, 2016, Effects of inositol(s) in women with PCOS: a systematic review of randomized controlled trials, Int J Endocrinol, 2016, 1, 10.1155/2016/1849162 · DOI
- Montanino Oliva, 2018, Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women, J Ovarian Res, 11, 38, 10.1186/s13048-018-0411-2 · DOI
- Greenberg, 2011, Folic acid supplementation and pregnancy: more than just neural tube defect prevention, Rev Obstet Gynecol, 4, 52
- Asbaghi, 2021, Effects of folic acid supplementation on oxidative stress markers: a systematic review and meta-analysis of randomized controlled trials, Antioxidants, 10, 871, 10.3390/antiox10060871 · DOI
- González, 2006, Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 336, 10.1210/jc.2005-1696 · DOI · Paper page
- Kazerooni, 2008, Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome, Int J Gynecol Obstet, 101, 156, 10.1016/j.ijgo.2007.10.024 · DOI
- Guzelmeric, 2007, Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome, Gynecol Endocrinol, 23, 505, 10.1080/09513590701554306 · DOI
- Kilicdag, 2005, Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial, Hum Reprod, 20, 1521, 10.1093/humrep/deh825 · DOI
- Bahmani, 2014, The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial, Clin Endocrinol (Oxf), 81, 582, 10.1111/cen.12451 · DOI
- Asemi, 2014, Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial, Mol Nutr Food Res, 58, 1465, 10.1002/mnfr.201400033 · DOI
- Loverro, 2002, The plasma homocysteine levels are increased in polycystic ovary syndrome, Gynecol Obstet Invest, 53, 157, 10.1159/000058367 · DOI
- Badawy, 2007, Plasma homocysteine and polycystic ovary syndrome: the missed link, Eur J Obstetr Gynecol Reprod Biol, 131, 68, 10.1016/j.ejogrb.2006.10.015 · DOI
- Yarali, 2001, Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome, Fertil Steril, 76, 511, 10.1016/S0015-0282(01)01937-9 · DOI · Paper page
- Kim, 2019, Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes, Medicine (Baltimore), 98, 10.1097/MD.0000000000017918 · DOI · Paper page
- Bartstra, 2021, Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2, Eur J Nutr, 60, 1691, 10.1007/s00394-020-02412-z · DOI
- Zoch, 2016, New insights into the biology of osteocalcin, Bone, 82, 42, 10.1016/j.bone.2015.05.046 · DOI · Paper page
- Schwalfenberg, 2017, Vitamins K1 and K2: the emerging group of vitamins required for human health, J Nutr Metab, 2017, 1, 10.1155/2017/6254836 · DOI · Paper page
- Tarkesh, 2020, Beneficial health effects of menaquinone-7 on body composition, glycemic indices, lipid profile, and endocrine markers in polycystic ovary syndrome patients, Food Sci Nutr, 8, 5612, 10.1002/fsn3.1837 · DOI
- Palamanda, 1993, Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione, Lipids, 28, 427, 10.1007/BF02535941 · DOI
- Wang, 2004, Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons, Am J Clin Nutr, 80, 649, 10.1093/ajcn/80.3.649 · DOI
- Cicek, 2012, Vitamin E effect on controlled ovarian stimulation of unexplained infertile women, J Assist Reprod Genet, 29, 325, 10.1007/s10815-012-9714-1 · DOI
- Izadi, 2019, Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome, J Clin Endocrinol Metab, 104, 319
- Ebrahimi, 2017, The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Exp Clin Endocrinol Diabetes, 125, 353, 10.1055/s-0042-117773 · DOI
- Chen, 2020, Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: a retrospective cohort study, BMC Women's Health, 20, 69, 10.1186/s12905-020-00930-w · DOI
- Hahn, 2007, Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism, Eur J Endocrinol, 157, 201, 10.1530/EJE-07-0143 · DOI · Paper page
- Tan, 2007, Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids, J Clin Endocrinol Metab, 92, 2764, 10.1210/jc.2007-0091 · DOI · Paper page
- Hosseini, 2021, Quercetin and metabolic syndrome: a review, Phytother Res, 35, 5352, 10.1002/ptr.7144 · DOI · Paper page
- Oh, 2014, Relationship between flavonoids intake and metabolic syndrome in Korean women with polycystic ovary syndrome, J Nutr Health, 47, 176, 10.4163/jnh.2014.47.3.176 · DOI
- Romualdi, 2008, Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study, Fertil Steril, 90, 1826, 10.1016/j.fertnstert.2007.09.020 · DOI
- Pourteymour Fard Tabrizi, 2020, Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review, J Ovarian Res, 13, 11, 10.1186/s13048-020-0616-z · DOI
- Salehi, 2019, Insights on the use of alpha-lipoic acid for therapeutic purposes, Biomolecules, 9, 356, 10.3390/biom9080356 · DOI · Paper page
- Packer, 2010, Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling, J Clin Biochem Nutr, 48, 26, 10.3164/jcbn.11-005FR · DOI · Paper page
- Prieto-Hontoria, 2013, Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats, Eur J Nutr, 52, 779, 10.1007/s00394-012-0384-7 · DOI
- Wang, 2010, alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice, Metabolism, 59, 967, 10.1016/j.metabol.2009.10.018 · DOI
- Masharani, 2010, Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome, J Diabetes Sci Technol, 4, 359, 10.1177/193229681000400218 · DOI
- Haghighatdoost, 2019, Does alpha-lipoic acid affect lipid profile? A meta-analysis and systematic review on randomized controlled trials, Eur J Pharmacol, 847, 1, 10.1016/j.ejphar.2019.01.001 · DOI
- Cianci, 2015, d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS, Gynecol Endocrinol, 31, 483, 10.3109/09513590.2015.1014784 · DOI
- Vigerust, 2012, Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment, Fertil Steril, 98, 1620, 10.1016/j.fertnstert.2012.08.024 · DOI
- Bene, 2018, Role of carnitine and its derivatives in the development and management of type 2 diabetes, Nutr Diabetes, 8, 8, 10.1038/s41387-018-0017-1 · DOI · Paper page
- Fenkci, 2008, Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome, Hum Reprod, 23, 1602, 10.1093/humrep/den109 · DOI
- Dunning, 2012, Promoting lipid utilization with l-carnitine to improve oocyte quality, Anim Reprod Sci, 134, 69, 10.1016/j.anireprosci.2012.08.013 · DOI
- Ringseis, 2012, Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency, Eur J Nutr, 51, 1, 10.1007/s00394-011-0284-2 · DOI · Paper page
- Salehpour, 2019, Effects of L-carnitine on polycystic ovary syndrome, JBRA Assist Reprod, 23, 392
- 2020, Gynecol Endocrinol, 1
- 2020, J Psychosom Obstet Gynaecol, 41, I, 10.1080/0167482X.2020.1842508 · DOI
- Jamilian, 2017, Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Gynecol Endocrinol, 33, 442, 10.1080/09513590.2017.1290071 · DOI · Paper page
- Ashoush, 2016, Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial, J Obstet Gynaecol Res, 42, 279, 10.1111/jog.12907 · DOI
- Jamilian, 2016, The effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 172, 72, 10.1007/s12011-015-0570-6 · DOI
- Jamilian, 2018, The influences of chromium supplementation on glycemic control, markers of cardio-metabolic risk, and oxidative stress in infertile polycystic ovary syndrome women candidate for in vitro fertilization: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 185, 48, 10.1007/s12011-017-1236-3 · DOI
- Fazelian, 2017, Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis, J Trace Elem Med Biol, 42, 92, 10.1016/j.jtemb.2017.04.008 · DOI
- Tang, 2018, Chromium supplementation in women with polycystic ovary syndrome: systematic review and meta-analysis, J Obstet Gynaecol Res, 44, 134, 10.1111/jog.13462 · DOI
- Kadoura, 2019, Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on menstrual cycle abnormalities, hormonal profile, and IGF-1 system in polycystic ovary syndrome patients: a randomized, placebo-controlled clinical trial, Adv Pharmacol Sci, 2019
- Panidis, 2005, Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome, Clin Chem, 51, 1691, 10.1373/clinchem.2005.052761 · DOI
- Hahn, 2006, Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome, Exp Clin Endocrinol Diabetes, 114, 577, 10.1055/s-2006-948308 · DOI · Paper page
- Szczuko, 2016, Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS), Rocz Panstw Zakl Hig, 67, 419
- Ahn, 2017, Calcium homeostasis in diabetes mellitus, J Vet Sci, 18, 261, 10.4142/jvs.2017.18.3.261 · DOI
- Gagnon, 2014, Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and beta-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial, PLoS One, 9, 10.1371/journal.pone.0109607 · DOI
- van Dam, 2006, Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women, Diabetes Care, 29, 2238, 10.2337/dc06-1014 · DOI · Paper page
- Sun, 2005, Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population, Diabetes, 54, 3336, 10.2337/diabetes.54.11.3336 · DOI · Paper page
- Voznesenskaya, 2015, Low-calcium diet prevents fructose-induced hyperinsulinemia and ameliorates the response to glucose load in rats, Nutr Metab, 12, 38, 10.1186/s12986-015-0035-0 · DOI
- Yim, 2008, Renin-angiotensin system – considerations for hypertension and kidney, Electrolyte Blood Press, 6, 42, 10.5049/EBP.2008.6.1.42 · DOI
- Belizan, 1984, The mediating role of the parathyroid gland in the effect of low calcium intake on blood pressure in the rat, Arch Latinoam Nutr, 34, 666
- Christakos, 2011, Vitamin D and intestinal calcium absorption, Mol Cell Endocrinol, 347, 25, 10.1016/j.mce.2011.05.038 · DOI · Paper page
- Foroozanfard, 2015, Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial, Clin Endocrinol (Oxf), 83, 888, 10.1111/cen.12840 · DOI
- Maktabi, 2018, Magnesium-zinc-calcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 182, 21, 10.1007/s12011-017-1085-0 · DOI
- Pal, 2012, Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome, Gynecol Endocrinol, 28, 965, 10.3109/09513590.2012.696753 · DOI
- Shokrpour, 2019, The effects of magnesium and vitamin E co-supplementation on hormonal status and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome, Biol Trace Elem Res, 191, 54, 10.1007/s12011-018-1602-9 · DOI
- Tinggi, 2008, Selenium: its role as antioxidant in human health, Environ Health Prev Med, 13, 102, 10.1007/s12199-007-0019-4 · DOI · Paper page
- Qazi, 2018, Selenium, selenoproteins, and female reproduction: a review, Molecules, 23, 10.3390/molecules23123053 · DOI
- Mirone, 2013, Selenium and reproductive function. A systematic review, J Endocrinol Invest, 36, 28
- Coskun, 2013, Plasma selenium levels in Turkish women with polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol, 168, 183, 10.1016/j.ejogrb.2013.01.021 · DOI
- Hajizadeh-Sharafabad, 2019, Selenium and polycystic ovary syndrome; current knowledge and future directions: a systematic review, Horm Metab Res, 51, 279, 10.1055/a-0890-6823 · DOI
- Maret, 2017, Zinc in cellular regulation: The nature and significance of “zinc signals”, Prev Nutr Food Sci, 22, 1, 10.3746/pnf.2017.22.1.1 · DOI
- Coulston, 1980, Insulin-like effect of zinc on adipocytes, Diabetes, 29, 665, 10.2337/diab.29.8.665 · DOI · Paper page
- Haase, 2003, Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling, Exp Cell Res, 291, 289, 10.1016/S0014-4827(03)00406-3 · DOI · Paper page
- Guler, 2014, Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance, Biol Trace Elem Res, 158, 297, 10.1007/s12011-014-9941-7 · DOI
- Jamilian, 2016, Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol Trace Elem Res, 170, 271, 10.1007/s12011-015-0480-7 · DOI
- Nasiadek, 2020, The role of zinc in selected female reproductive system disorders, Nutrients, 12, 10.3390/nu12082464 · DOI
- Shamasbi, 2020, The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis, Eur J Nutr, 59, 433, 10.1007/s00394-019-02033-1 · DOI
- Adriaens, 2006, Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis, Toxicology, 228, 333, 10.1016/j.tox.2006.09.018 · DOI · Paper page
- Tamura, 2009, Melatonin and the ovary: physiological and pathophysiological implications, Fertil Steril, 92, 328, 10.1016/j.fertnstert.2008.05.016 · DOI · Paper page
- Wei, 2013, Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro, J Assist Reprod Genet, 30, 933, 10.1007/s10815-013-0021-2 · DOI
- Sirotkin, 1997, Direct regulation of mammalian reproductive organs by serotonin and melatonin, J Endocrinol, 154, 1, 10.1677/joe.0.1540001 · DOI
- Hu, 2020, Melatonin application in assisted reproductive technology: a systematic review and meta-analysis of randomized trials, Front Endocrinol, 11, 160, 10.3389/fendo.2020.00160 · DOI
- Al-Q, 2018, Effect of melatonin supplementation on serum LH level and BMI in women with polycystic ovary syndrome, J Pharm Sci Res, 10, 1
- Poudyal, 2011, Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action, Prog Lipid Res, 50, 372, 10.1016/j.plipres.2011.06.003 · DOI · Paper page
- Shahnazi, 2015, Influence of omega-3 fatty acid eicosapentaenoic acid on IGF-1 and COX-2 gene expression in granulosa cells of PCOS women, Iran J Reprod Med, 13, 71
- Meng, 2021, Anti-inflammatory action and mechanisms of resveratrol, Molecules (Basel, Switzerland), 26, 229, 10.3390/molecules26010229 · DOI · Paper page
- Shojaei-Zarghani, 2021, Resveratrol and markers of polycystic ovary syndrome: a systematic review of animal and clinical studies, Reprod Sci
- Amin, 2014, Novel coq10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats, PLoS One, 9, 10.1371/journal.pone.0089169 · DOI
- Martelli, 2020, Coenzyme Q(4): clinical applications in cardiovascular diseases, Antioxidants, 9, 341, 10.3390/antiox9040341 · DOI
- Samimi, 2017, The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Clin Endocrinol (Oxf), 86, 560, 10.1111/cen.13288 · DOI · Paper page
- Ruderman, 2013, AMPK, insulin resistance, and the metabolic syndrome, J Clin Invest, 123, 2764, 10.1172/JCI67227 · DOI · Paper page
- Mani, 2011, An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus, J Diet Suppl, 8, 257, 10.3109/19390211.2011.593615 · DOI · Paper page
- Haidari, 2020, The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial, Nutr J, 19, 8, 10.1186/s12937-020-0524-5 · DOI · Paper page
- Hou, 2019, Beneficial effects of pomegranate on lipid metabolism in metabolic disorders, Mol Nutr Food Res, 63
- Rom, 2017, Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice, Arch Toxicol, 91, 1709, 10.1007/s00204-016-1859-8 · DOI
- Esmaeilinezhad, 2020, The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial, J Endocrinol Invest, 43, 539, 10.1007/s40618-019-01139-x · DOI
- Esmaeilinezhad, 2019, Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: a randomized, triple blind, controlled trial, Nutr Metab Cardiovasc Dis, 29, 201, 10.1016/j.numecd.2018.07.002 · DOI
- Martinez-Garcia, 2009, Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism, Diabetes Care, 32, 1525, 10.2337/dc09-0420 · DOI
- Escobar-Morreale, 2012, Iron metabolism and the polycystic ovary syndrome, Trends Endocrinol Metab, 23, 509, 10.1016/j.tem.2012.04.003 · DOI
- Luque-Ramirez, 2007, Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses, Diabetes Care, 30, 2309, 10.2337/dc07-0642 · DOI
- Medagama, 2015, The glycaemic outcomes of cinnamon, a review of the experimental evidence and clinical trials, Nutr J, 14, 108, 10.1186/s12937-015-0098-9 · DOI · Paper page
- Ong, 2017, Chinese herbal medicine for the optimal management of polycystic ovary syndrome, Am J Chin Med, 45, 405, 10.1142/S0192415X17500252 · DOI
- Chang, 2016, Evaluation of the in vivo therapeutic effects of radix paeoniae rubra ethanol extract with the hypoglycemic activities measured from multiple cell-based assays, Evid Based Complement Alternat Med, 2016, 10.1155/2016/3262790 · DOI
- Zhou, 2016, Chinese herbal medicine for subfertile women with polycystic ovarian syndrome, Cochrane Database Syst Rev, 10
- Zhang, 2013, Curcumin and diabetes: a systematic review, Evid Based Complement Alternat Med, 2013, 10.1155/2013/636053 · DOI · Paper page
- Ghowsi, 2020, Effects of Salvia officinalis L. (common sage) leaves tea on insulin resistance, lipid profile, and oxidative stress in rats with polycystic ovary: an experimental study, Avicenna J Phytomed, 10, 263
- Badgujar, 2014, Biomed Res Int, 2014, 10.1155/2014/842674 · DOI · Paper page
- Sadeghi Ataabadi, 2017, Role of essential oil of Mentha spicata (Spearmint) in addressing reverse hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome in a rat model, Adv Pharm Bull, 7, 651, 10.15171/apb.2017.078 · DOI
- Chen, 2012, Protective effects of sweet orange (Citrus sinensis) peel and their bioactive compounds on oxidative stress, Food Chem, 135, 2119, 10.1016/j.foodchem.2012.07.041 · DOI
- Ali, 2008, Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale roscoe): a review of recent research, Food Chem Toxicol, 46, 409, 10.1016/j.fct.2007.09.085 · DOI · Paper page
- Ainehchi, 2019, Biomolecules, 9, 215, 10.3390/biom9060215 · DOI
- Zhang, 2017, Acupuncture for the treatment of obesity in adults: a systematic review and meta-analysis, Postgrad Med J, 93, 743, 10.1136/postgradmedj-2017-134969 · doi:10.1136/postgradmedj-2017-134969
- Richards, 1998, Stimulation of auricular acupuncture points in weight loss, Aust Fam Physician, 27, S73
- Li, 2015, Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet-induced obese rats, Nutrition, 31, 1416, 10.1016/j.nut.2015.05.007 · DOI
- Firouzjaei, 2016, Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients, Nutr Diabetes, 6, e209, 10.1038/nutd.2016.16 · DOI
- Gucel, 2012, Influence of acupuncture on leptin, ghrelin, insulin and cholecystokinin in obese women: a randomised, sham-controlled preliminary trial, Acupunct Med, 30, 203, 10.1136/acupmed-2012-010127 · DOI
- Hsu, 2009, The effect of auricular acupuncture in obese women: a randomized controlled trial, J Women's Health, 18, 813, 10.1089/jwh.2008.1005 · DOI
- Lin, 2014, Acupoint-specific, frequency-dependent, and improved insulin sensitivity hypoglycemic effect of electroacupuncture applied to drug-combined therapy studied by a randomized control clinical trial, Evid Based Complement Alternat Med, 2014, 10.1155/2014/371475 · DOI
- Lin, 2011, Electroacupuncture improves glucose tolerance through cholinergic nerve and nitric oxide synthase effects in rats, Neurosci Lett, 494, 114, 10.1016/j.neulet.2011.02.071 · DOI
- Lin, 2009, Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats, BMC Complement Altern Med, 9, 26, 10.1186/1472-6882-9-26 · DOI
- Liang, 2010, Acupuncture: is it effective for treatment of insulin resistance?, Diabetes Obes Metab, 12, 555, 10.1111/j.1463-1326.2009.01192.x · DOI
- Peplow, 2012, Electroacupuncture for control of blood glucose in diabetes: literature review, J Acupunct Meridian Stud, 5, 1, 10.1016/j.jams.2011.11.018 · DOI
- Wang, 2008, Electroacupuncture in the treatment of obesity, Neurochem Res, 33, 2023, 10.1007/s11064-008-9822-6 · DOI
- Stener-Victorin, 2008, Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence, J Neuroendocrinol, 20, 290, 10.1111/j.1365-2826.2007.01634.x · DOI
- Stener-Victorin, 2006, Ovarian blood flow responses to electroacupuncture stimulation depend on estrous cycle and on site and frequency of stimulation in anesthetized rats, J Appl Physiol (Bethesda, MD: 2006), 101, 84, 10.1152/japplphysiol.01593.2005 · DOI
- Wu, 2020, Effectiveness of acupuncture in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials, Medicine (Baltimore), 99, 10.1097/MD.0000000000020441 · DOI
- Qu, 2016, The effects of acupuncture on polycystic ovary syndrome: a systematic review and meta-analysis, Eur J Integr Med, 8, 12, 10.1016/j.eujim.2016.02.001 · DOI
- Monro, 1997, Yoga therapy, J Bodyw Mov Ther, 1, 215, 10.1016/S1360-8592(97)80047-2 · DOI
- Shele, 2020, A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome, J Funct Morphol Kinesiol, 5, 35, 10.3390/jfmk5020035 · DOI · Paper page
- Verma, 2021, Effect of yoga therapy on health outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis, Am J Lifestyle Med
- Thakur, 2021, Effect of yoga on polycystic ovarian syndrome: a systematic review, J Bodyw Mov Therap, 27, 281, 10.1016/j.jbmt.2021.02.018 · DOI
- Mohseni, 2021, Yoga effects on anthropometric indices and polycystic ovary syndrome symptoms in women undergoing infertility treatment: a randomized controlled clinical trial, Evid Based Complement Alternat Med, 2021, 10.1155/2021/5564824 · DOI
- Selvaraj, 2020, Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India, Health Sci Rep, 3, e212, 10.1002/hsr2.212 · DOI
- Stefanaki, 2015, Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial, Stress (Amsterdam, Netherlands), 18, 57, 10.3109/10253890.2014.974030 · DOI
- Gupta, 2017, Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications, Diabetol Metab Syndr, 9, 59, 10.1186/s13098-017-0254-9 · DOI · Paper page
Cited by
Muhammed Saeed, A. A., Noreen, S., Awlqadr, F. H., Farooq, M. I., Qadeer, M., Rai, N., Farag, H. A., & Saeed, M. N. (2025) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-025-00899-y · Cited by 29
“Addressing these deficiencies can improve learning outcomes for women with PCOS [69].”
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Albardan, L., Platat, C., & Kalupahana, N. S. (2024) · Nutrients · doi:10.3390/nu16172961 · Cited by 18
“Potential benefits of dietary supplements in the management of PCOS have been previously reviewed by Iervolino et al. [54] and Alesi et al. [18].”
BackgroundShao, F., Xu, S., Zhao, H., Zhang, F., Wang, X., & Wang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1420004 · Cited by 8
Shen, J.-Y., Xu, L., Ding, Y., & Wu, X.-Y. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i23.5468 · Cited by 7
Metadata
- Authors
- Alesi, S., Ee, C., Moran, L. J., Rao, V., & Mousa, A.
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 13
- Issue
- 4
- Pages
- 1243-1266
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- OpenAlex
- W4207014251
- Cited by
- 146
- References
- 47
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 214 d)
- Funders
- Monash University
- National Heart Foundation
- Jacka Foundation of Natural Therapies
- National Health and Medical Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.